Tagged with Biotech,

Pharma Colette Alma-Zeestraten tells PharmaBoardroom about how the Dutch Pharma Industry is adapting, how it is making use of clusters to become more competitive, energy efficient, and innovative, and how the nine billion euro contribution the pharmaceuticals sector makes to the Dutch chemicals industry. Over your last 10 years at the VNCI, what…

Holland Pharming Group CEO Sijmen de Vries discusses the advantages of his company’s transgenic platform for recombinant protein production, the commercial progress of their lead product Ruconest, and the company’s plans for developing new applications through the platform, including a partnership with the SinoPharm subsidiary SIPI. From a production point of…

Holland A serial entrepreneur, Henk Viëtor founded the Drug Discovery Factory as an active venture fund focused on translating life science research into medical innovation. He discusses his perspective on the Dutch startup environment, and makes his case for how the country should proceed if it is serious about supporting the…

Holland Pivot Park in Oss, the Netherlands, aims at becoming an inspiring campus for open innovation in life sciences. The CEO discusses the unique assets the park offers to companies and calls for an increased collaboration among private industry, academia, and government to enhance the country’s global competitiveness. You took over…

Holland Floris de Gelder & Friso Smit share the story of Utrecht Science Park, the fastest growing science park in the Netherlands. The park’s companies do work in the fields of food and health, oncology, organoid technology, regenerative medicine, and personalized health. Mr de Gelder and Mr Smit share their vision for…

Holland Thijs De Kleer, Managing Director, Saco de Visser, Director Cluster Development, discuss recent developments at the Netherlands largest science park and how Leiden has positioned itself as a leader in early stages of development, which creates a great environment to foster innovation. Leiden lies at the center of the Dutch…

investment The new government of Mauritius has chosen pharmaceuticals, healthcare and life sciences as priorities for the country’s innovation economy. Pharmaboardroom spoke with Ameenah Gurib Fakim, president of the Republic of Mauritius, who outlined her country’s strengths, and the challenge of replacing the country’s conventional “sun and sand” image with life sciences. Mauritius’ successful growth…

Steri-Tech Steri-Tech is one of the few local contract sterilization service providers available in Puerto Rico. Jorge and Andy Vivoni, president and business development manager, discuss how they ensure that pharmaceutical companies continue to establish themselves in Puerto Rico. What is the strategic importance of Steri-Tech within the Puerto Rican life sciences…

biotech Ignacio Pino, president of CDI Laboratories Inc., discusses how his novel technology platform Hu-Prot will help pharmaceutical companies and academia develop drugs more efficiently through development of advanced antibodies. How do you perceive the local life sciences industry of Puerto Rico? There is an increase in activity but still ample…

Allergan Frank Rodríguez, General Manager for Allergan Operations in Puerto Rico, discusses cost-competitiveness at his plants in Fajardo and Manatí, which manufacture hormones and solid dosage forms respectively. He also outlines the company’s recent $48 million investment in expanding these facilities. What were the initial priorities you set? When I arrived…

local company Turkey’s leading pharmaceutical company is in the process of developing production facilities abroad, and it has just begun construction of a USD 100 million biotech facility; CEO Süha Taşpolatoğlu believes that these two steps will help bring the company closer to its aspiration of becoming a pharmaceutical player on the…

biotech Local flagship company Boryung has found success with its newly developed angiotension receptor blocker (ARB) Kanarb. Nine molecules currently exist worldwide in this category of antihypertensives, and Kanarb is currently ranked eighth. “Boryung is the only domestic company that has developed a drug from start to finish, including outlicensing. Of…